Retatrutide 10mg
Retatrutide 10 mg represents the latest generation of peptides in metabolic research. As an innovative triple agonist, the substance simultaneously targets three core receptors (GLP-1, GIP, and GCGR). This synergistic combination makes Retatrutide one of the most advanced research compounds for investigating cellular energy homeostasis and weight regulation.
Choose a variant
This product is intended exclusively for laboratory and research purposes. Not intended for direct use or human consumption. For persons over 18 years of age only.
About the product
Retatrutide 10 mg represents the latest generation of peptides in metabolic research. As an innovative triple agonist, the substance simultaneously targets three core receptors (GLP-1, GIP, and GCGR). This synergistic combination makes Retatrutide one of the most advanced research compounds for investigating cellular energy homeostasis and weight regulation.
Synergistic Triple Mechanism: Parallel stimulation of GLP-1, GIP, and glucagon receptors for maximum metabolic efficiency.
Fat Metabolism Research: Targeted investigation into increasing basal metabolic rate and optimizing lipolysis.
Satiety & Appetite Regulation: Pronounced impact on delayed gastric emptying and central feeding pathways.
Glucose Homeostasis: High potential for researching insulin sensitivity and blood sugar stabilization.
Composition & specifications
The information below is for reference only and is intended exclusively for research purposes. It is not medical advice.
Dosing information will be provided according to the specific research protocol.
Upon receiving the shipment, place the product in a refrigerator immediately (2–8 °C). Do not freeze.
Protect from direct sunlight and heat sources. Keep in the original sealed packaging.
When stored correctly, the product is stable for the period indicated on the packaging. Use according to batch specification after opening.
What is this product intended for?
Other products
